...
首页> 外文期刊>European review for medical and pharmacological sciences. >Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1
【24h】

Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1

机译:下调lncRNA MEG3促进大肠腺癌细胞增殖,并通过上调TGF-β1及其下游鞘氨醇激酶1抑制细胞凋亡

获取原文
           

摘要

OBJECTIVE: LncRNA MEG3 is involved in the pathogenesis of several types of cancers. While its participation and function network in colorectal (CR) adenocarcinoma, which is one of the most common malignancies, still hasn’t been well studied. Therefore, our study aimed to investigate the role of MEG3 in colorectal adenocarcinoma and to explore the possibly related mechanisms. PATIENTS AND METHODS: Tumor tissues and adjacent healthy tissues were collected from colorectal adenocarcinoma patients. Blood samples were collected from both colorectal adenocarcinoma patients and healthy controls to prepare serum sample. Expression of MEG3 in those tissues was detected by qRT-PCR. MEG3 knockdown and sphingosine kinase 1 (SPHK1) overexpression colorectal adenocarcinoma cell lines were established. Its effects on cell proliferation and apoptosis were investigated by CCK-8 assay and MTT assay, respectively. Effects of MEG3 overexpression on TGF-β1 and SPHK1 were investigated by Western blot. RESULTS: MEG3 expression level was decreased in tumor tissues than that in adjacent healthy tissues. Serum level of MEG3 was lower in cancer patients than that in healthy controls, and the serum level decreased with the increased stage of primary tumor. Serum TGF-β1 can be used to predict colorectal adenocarcinoma and its prognosis accurately. MEG3 knockdown and SPHK1 overexpression promoted tumor cell proliferation, but inhibited cell apoptosis. MEG3 knockdown also increased the expression level of TGF-β1 and SPHK1. Treatment with TGF-β1 inhibitor reduced the expression level of SPHK1 but showed no significant effects on MEG3. SPHK1 overexpression showed no significant effects on MEG3 and TGF-β1 expression. CONCLUSIONS: Downregulation of lncRNA MEG3 can promote colorectal adenocarcinoma cell proliferation and inhibit the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
机译:目的:LncRNA MEG3参与多种类型癌症的发病机制。尽管它在最常见的恶性肿瘤之一-大肠腺癌中的参与和功能网络仍未得到很好的研究。因此,我们的研究旨在探讨MEG3在结直肠腺癌中的作用,并探讨可能的相关机制。患者与方法:从大肠腺癌患者中收集肿瘤组织和邻近的健康组织。从大肠腺癌患者和健康对照者收集血液样品以制备血清样品。通过qRT-PCR检测MEG3在那些组织中的表达。建立了MEG3基因敲低和鞘氨醇激酶1(SPHK1)过表达的结直肠腺癌细胞系。分别通过CCK-8试验和MTT试验研究了其对细胞增殖和凋亡的影响。通过蛋白质印迹法研究了MEG3过表达对TGF-β1和SPHK1的影响。结果:MEG3在肿瘤组织中的表达水平低于癌旁健康组织。癌症患者的血清MEG3水平低于健康人,并且血清水平随着原发肿瘤分期的增加而降低。血清TGF-β1可用于准确预测大肠腺癌及其预后。 MEG3基因敲低和SPHK1过表达促进肿瘤细胞增殖,但抑制细胞凋亡。 MEG3敲低还增加了TGF-β1和SPHK1的表达水平。用TGF-β1抑制剂治疗可降低SPHK1的表达水平,但对MEG3无明显影响。 SPHK1过表达对MEG3和TGF-β1表达无显着影响。结论:lncRNA MEG3的下调可通过上调TGF-β1及其下游鞘氨醇激酶1促进大肠腺癌细胞的增殖并抑制细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号